Target and Pathway |
Top |
Target(s) |
Janus kinase 2 (JAK-2) |
Target Info
|
Inhibitor |
[1] |
Proto-oncogene c-Src (SRC) |
Target Info
|
Inhibitor |
[1] |
Target's Patent Info |
Janus kinase 2 (JAK-2) |
Target's Patent Info
|
[1] |
Proto-oncogene c-Src (SRC) |
Target's Patent Info
|
[1] |
KEGG Pathway
|
Chemokine signaling pathway
|
PI3K-Akt signaling pathway
|
Signaling pathways regulating pluripotency of stem cells
|
Jak-STAT signaling pathway
|
Cholinergic synapse
|
Prolactin signaling pathway
|
Adipocytokine signaling pathway
|
Leishmaniasis
|
Toxoplasmosis
|
Tuberculosis
|
Measles
|
Influenza A
|
Herpes simplex infection
|
ErbB signaling pathway
|
Rap1 signaling pathway
|
Endocytosis
|
VEGF signaling pathway
|
Focal adhesion
|
Adherens junction
|
Tight junction
|
Gap junction
|
Platelet activation
|
GABAergic synapse
|
Inflammatory mediator regulation of TRP channels
|
Regulation of actin cytoskeleton
|
GnRH signaling pathway
|
Estrogen signaling pathway
|
Thyroid hormone signaling pathway
|
Oxytocin signaling pathway
|
Bacterial invasion of epithelial cells
|
Epithelial cell signaling in Helicobacter pylori infection
|
Shigellosis
|
Hepatitis B
|
Viral carcinogenesis
|
Proteoglycans in cancer
|
NetPath Pathway
|
IL2 Signaling Pathway
|
Panther Pathway
|
Inflammation mediated by chemokine and cytokine signaling pathway
|
Interferon-gamma signaling pathway
|
JAK/STAT signaling pathway
|
PDGF signaling pathway
|
PI3 kinase pathway
|
CCKR signaling map ST
|
Angiogenesis
|
Cadherin signaling pathway
|
Integrin signalling pathway
|
Parkinson disease
|
Pathway Interaction Database
|
Endothelins
|
ErbB4 signaling events
|
GMCSF-mediated signaling events
|
IL4-mediated signaling events
|
IL27-mediated signaling events
|
Signaling events mediated by PTP1B
|
IL12-mediated signaling events
|
S1P3 pathway
|
SHP2 signaling
|
CXCR4-mediated signaling events
|
IL5-mediated signaling events
|
IFN-gamma pathway
|
ErbB2/ErbB3 signaling events
|
IL3-mediated signaling events
|
IL6-mediated signaling events
|
PDGFR-beta signaling pathway
|
IL23-mediated signaling events
|
Signaling events mediated by Stem cell factor receptor (c-Kit)
|
EPO signaling pathway
|
Notch-mediated HES/HEY network
|
Signaling events mediated by PRL
|
LPA receptor mediated events
|
Atypical NF-kappaB pathway
|
Glypican 1 network
|
Plasma membrane estrogen receptor signaling
|
Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met)
|
EPHB forward signaling
|
Nectin adhesion pathway
|
Regulation of p38-alpha and p38-beta
|
CDC42 signaling events
|
Signaling events regulated by Ret tyrosine kinase
|
Arf6 signaling events
|
Signaling events mediated by TCPTP
|
FAS (CD95) signaling pathway
|
Thromboxane A2 receptor signaling
|
Netrin-mediated signaling events
|
Alpha9 beta1 integrin signaling events
|
EGF receptor (ErbB1) signaling pathway
|
Class I PI3K signaling events
|
Posttranslational regulation of adherens junction stability and dissassembly
|
Regulation of Androgen receptor activity
|
E-cadherin signaling in the nascent adherens junction
|
amb2 Integrin signaling
|
Integrins in angiogenesis
|
ErbB1 downstream signaling
|
Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling
|
EPHA forward signaling
|
E-cadherin signaling in keratinocytes
|
Nongenotropic Androgen signaling
|
Internalization of ErbB1
|
CXCR3-mediated signaling events
|
Signaling events mediated by VEGFR1 and VEGFR2
|
Syndecan-2-mediated signaling events
|
Class I PI3K signaling events mediated by Akt
|
Syndecan-3-mediated signaling events
|
Ephrin B reverse signaling
|
Trk receptor signaling mediated by PI3K and PLC-gamma
|
EPHA2 forward signaling
|
Alpha-synuclein signaling
|
FGF signaling pathway
|
Alpha4 beta1 integrin signaling events
|
Signaling events mediated by focal adhesion kinase
|
Reactome
|
Interleukin-6 signaling
|
MAPK3 (ERK1) activation
|
MAPK1 (ERK2) activation
|
GPVI-mediated activation cascade
|
Prolactin receptor signaling
|
RMTs methylate histone arginines
|
G beta:gamma signalling through PI3Kgamma
|
Interleukin-3, 5 and GM-CSF signaling
|
RAF activation
|
RAF/MAP kinase cascade
|
Interferon gamma signaling
|
Regulation of IFNG signaling
|
Interleukin receptor SHC signaling
|
Growth hormone receptor signaling
|
Factors involved in megakaryocyte development and platelet production
|
WikiPathways
|
Serotonin Receptor 2 and STAT3 Signaling
|
Type II interferon signaling (IFNG)
|
Notch Signaling Pathway
|
EPO Receptor Signaling
|
EGF/EGFR Signaling Pathway
|
IL-4 Signaling Pathway
|
IL-6 signaling pathway
|
Kit receptor signaling pathway
|
IL-3 Signaling Pathway
|
Mesodermal Commitment Pathway
|
Interleukin-2 signaling
|
Signaling by SCF-KIT
|
Prolactin receptor signaling
|
Growth hormone receptor signaling
|
JAK/STAT
|
BDNF signaling pathway
|
Oncostatin M Signaling Pathway
|
Interleukin-11 Signaling Pathway
|
AGE/RAGE pathway
|
TSLP Signaling Pathway
|
IL17 signaling pathway
|
Leptin signaling pathway
|
TSH signaling pathway
|
Interleukin-3, 5 and GM-CSF signaling
|
Interferon gamma signaling
|
Factors involved in megakaryocyte development and platelet production
|
IL-5 Signaling Pathway
|
ErbB Signaling Pathway
|
Senescence and Autophagy in Cancer
|
TGF beta Signaling Pathway
|
Signaling of Hepatocyte Growth Factor Receptor
|
Pregnane X Receptor pathway
|
Aryl Hydrocarbon Receptor Pathway
|
Nanoparticle-mediated activation of receptor signaling
|
Polycystic Kidney Disease Pathway
|
Alpha 6 Beta 4 signaling pathway
|
Integrated Pancreatic Cancer Pathway
|
Signaling Pathways in Glioblastoma
|
Arylhydrocarbon receptor (AhR) signaling pathway
|
Regulation of Microtubule Cytoskeleton
|
FSH signaling pathway
|
RANKL/RANK Signaling Pathway
|
Integrin-mediated Cell Adhesion
|
Angiogenesis
|
Androgen receptor signaling pathway
|